Stock ACTG ACACIA RESEARCH CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News Acacia Research Corporation

Equities

ACTG

US0038813079

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-16 pm EDT 		5-day change 1st Jan Change
4.93 USD -0.40% Intraday chart for Acacia Research Corporation -5.19% +25.77%
Mar. 15 Tranche Update on Acacia Research Corporation's Equity Buyback Plan announced on November 13, 2023. CI
Mar. 14 Acacia Research Q4 Swings to Profit, Revenue Increases MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tranche Update on Acacia Research Corporation's Equity Buyback Plan announced on November 13, 2023.
CI
Acacia Research: Q4 Earnings Snapshot
AQ
Acacia Research Q4 Swings to Profit, Revenue Increases
MT
Acacia Research Seeks Acquisitions
CI
Transcript : Acacia Research Corporation, Q4 2023 Earnings Call, Mar 14, 2024
Acacia Research Reports Fourth Quarter 2023 Financial Results
BU
Earnings Flash (ACTG) ACACIA RESEARCH CORPORATION Posts Q4 Revenue $92.3M
MT
Acacia Research Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Acacia Research to Release Fourth Quarter and Full Year 2023 Financial Results on March 14
BU
Acacia Research Expands Oil and Gas Investments Through Benchmark Energy’s Transformative Acquisition in the Western Anadarko Basin
BU
Acacia Research Corporation Announces Board Changes
CI
Acacia Research Appoints Martin McNulty Jr. as Permanent CEO
MT
Acacia Research Appoints Martin (“MJ”) D. McNulty, Jr. to Board of Directors, Named Permanent CEO
BU
Acacia Research Corporation Appoints Martin D. Mcnulty as Director
CI
Acacia Research Corporation Appoints Martin D. Mcnulty, Jr. as Permanent Chief Executive Officer
CI
Katoro Gold launches fundraising, eyes board shake-up
AN
Arix Bioscience shares suspended ahead of RTW takeover
AN
Acacia Research Announces Licensing and Settlement Agreements Related to WiFi-6 Patents
BU
RTW Biotech Buys Minority Stake in Arix Bioscience to Support Planned Takeover
MT
Rtw Biotech Opportunities Operating Ltd completed the acquisition of a 26.6% stake in Arix Bioscience plc from Acacia Research Corporation for £47.2 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ACTG Stock
  4. News Acacia Research Corporation